BeatO appoints Dr. Navneet Agrawal as Chief Clinical Officer
People

BeatO appoints Dr. Navneet Agrawal as Chief Clinical Officer

He has published more than 100 research papers in several prestigious national and international journals

  • By IPP Bureau | December 22, 2022

BeatO, a comprehensive digital diabetes care platform for controlling and reversing diabetes, has announced the appointment of Dr. Navneet Agrawal as its Chief Clinical Officer (CCO).

Agrawal will head BeatO’s proprietary Diabetes Care Programs. He has over 22 years of clinical experience and more than 16 years of teaching experience. He has published more than 100 research papers in several prestigious national and international journals.

Agrawal has designed the clinically verified BeatO Diabetes Care Programs which provide personalized digital care solutions with proactive and supervised diabetes counseling by doctors and health experts on diet planning, exercise advice, and medication. The program has over 25,000 enrolled users and is tailor-made for people with pre-diabetes, type 2 diabetes, gestational diabetes, and type 1 diabetes.

Speaking on his appointment, Gautam Chopra, Co-Founder & CEO, BeatO said, “We welcome Dr. Navneet Agrawal to lead our unique and personalized Diabetes Care Programs at BeatO. Dr. Agrawal has the experience of treating over a lakh diabetes patients from the length and breadth of India, cutting across demographical, geographical, and economical strata. His rich experience has provided great insights into designing BeatO’s Diabetes Care Programs which are clinically validated and solve the problem of accessibility and affordability for continuous diabetes care and help empower patients to achieve positive health outcomes.”

Agrawal said, “With diabetes growing at an alarming rate in our society and reaching epidemic proportions, continuous and comprehensive care combined with technology and digital tools is the only way to provide personalized and intensive solutions for the millions afflicted. With virtual consultations, continuous care, support, and regular monitoring, we can help people with diabetes achieve their target HbA1c levels and avoid complications that arise from uncontrolled sugar levels and live long and healthy lives.”

Upcoming E-conference

Other Related stories

Startup

Digitization